Cardinal Health approves quarterly dividend of $0.3425 per share

Download PDF Copy

Feb 4 2015

Cardinal Health today announced that its board of directors approved a quarterly dividend of $0.3425 per share.

This quarterly dividend will be payable on April 15 to shareholders of record on April 1.

SOURCE Cardinal Health

Posted in: Business / Finance

Comments (0)

Download PDF Copy

Suggested Reading

Investing in adolescent mental health delivers long-term economic and social benefits

Investing in adolescent mental health delivers long-term economic and social benefits

Survey reveals strong public desire for notification about AI use in healthcare

Survey reveals strong public desire for notification about AI use in healthcare

A reduction in BMI among adults is associated with lower health care spending, study suggests

A reduction in BMI among adults is associated with lower health care spending, study suggests

Digital avatars may ease distress from troubling voices in psychosis

Digital avatars may ease distress from troubling voices in psychosis

Psilocybin therapy reduces depression in clinicians after pandemic frontline work

Psilocybin therapy reduces depression in clinicians after pandemic frontline work

Can AI be your therapist? Study shows ChatGPT outperforms professionals in key areas

Can AI be your therapist? Study shows ChatGPT outperforms professionals in key areas

Study finds health care evaluations of large language models lacking in real patient data and bias assessment

Study finds health care evaluations of large language models lacking in real patient data and bias assessment

Traditional Kava rituals provide alternative pathway to PTSD recovery

Traditional Kava rituals provide alternative pathway to PTSD recovery

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

How innovation in dried blood spot testing is transforming neurological disease monitoring